Affymetrix Sues Illumina Over Gene Detection Patent

Law360, New York (August 5, 2004, 12:00 AM EDT) -- Affymetrix Inc., the leading producer of gene-detection devices, has sued rival Illumina Inc. over patents for a technology used to track genetic differences and to identify which genes are activated in particular types of cells.

The suit, filed in U.S. District Court for the District of Delaware, alleges infringement of six Affymetrix patents, related to aspects of software, hardware and arrays, which are used for DNA sequencing and other purposes.

Affymetrix, which is seeking royalties, said it went to court reluctantly ``after many good-faith efforts to...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.